Operating Lease, Right-of-Use Asset of Inozyme Pharma, Inc. from 31 Dec 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inozyme Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
  • Inozyme Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $410,000, a 59% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Inozyme Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $410,000 -$582,000 -59% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $562,000 -$564,000 -50% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 $710,000 -$546,000 -43% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $853,000 -$528,000 -38% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $992,000 -$511,000 -34% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,126,000 -$494,000 -30% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $1,256,000 -$478,000 -28% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,381,000 -$463,000 -25% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,503,000 -$447,000 -23% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,620,000 -$433,000 -21% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $1,734,000 -$418,000 -19% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,844,000 -$404,000 -18% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,950,000 -$391,000 -17% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $2,053,000 +$2,053,000 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $2,152,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $2,248,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $2,341,000 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $0 31 Dec 2020 10-K 15 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.